Sylvia Ma

821 total citations
11 papers, 437 citations indexed

About

Sylvia Ma is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sylvia Ma has authored 11 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Sylvia Ma's work include Cancer therapeutics and mechanisms (4 papers), Synthesis and biological activity (3 papers) and Quinazolinone synthesis and applications (3 papers). Sylvia Ma is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Synthesis and biological activity (3 papers) and Quinazolinone synthesis and applications (3 papers). Sylvia Ma collaborates with scholars based in United States, Switzerland and Japan. Sylvia Ma's co-authors include Johanna M. Jansen, S. Arnold, Douglas J. Tigert, Paul A. Renhowe, Thomas G. Gesner, Cynthia M. Shafer, Christopher M. McBride, Daniel E. Lopes de Menezes, Millicent Embry and Barbara Hibner and has published in prestigious journals such as Journal of Molecular Biology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sylvia Ma

11 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvia Ma United States	10	281	170	126	44	36	11	437
Chad Quinn United States	9	253 0.9×	97 0.6×	70 0.6×	26 0.6×	16 0.4×	15	451
Jiachen Wen China	10	159 0.6×	127 0.7×	77 0.6×	22 0.5×	3 0.1×	23	353
M.Á. Gallo Spain	11	103 0.4×	105 0.6×	32 0.3×	12 0.3×	8 0.2×	30	355
Steven Gunawan United States	11	180 0.6×	152 0.9×	57 0.5×	25 0.6×	6 0.2×	20	371
Franck Augé France	10	183 0.7×	83 0.5×	75 0.6×	11 0.3×	5 0.1×	24	410
Stephen M. Canham United States	12	380 1.4×	303 1.8×	70 0.6×	29 0.7×	41 1.1×	15	747
Sabarni K. Chatterjee United States	11	335 1.2×	113 0.7×	171 1.4×	22 0.5×	90 2.5×	11	642
Hye‐Sook Han South Korea	10	136 0.5×	12 0.1×	198 1.6×	4 0.1×	26 0.7×	17	583
Smitha Kizhake United States	14	310 1.1×	132 0.8×	162 1.3×	36 0.8×	42 1.2×	20	490
Stéphanie Blanchard Singapore	12	323 1.1×	166 1.0×	166 1.3×	59 1.3×	33 0.9×	29	548

Countries citing papers authored by Sylvia Ma

Since Specialization

Citations

This map shows the geographic impact of Sylvia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvia Ma more than expected).

Fields of papers citing papers by Sylvia Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvia Ma. The network helps show where Sylvia Ma may publish in the future.

Co-authorship network of co-authors of Sylvia Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvia Ma. A scholar is included among the top collaborators of Sylvia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvia Ma. Sylvia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Blais, Johanne, Charles R. Dean, Guillaume Lapointe, et al.. (2022). In Vitro and In Vivo Properties of CUO246, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor. Antimicrobial Agents and Chemotherapy. 66(12). e0092122–e0092122. 2 indexed citations

Lu, Yipin, Mark Knapp, Kenneth Crawford, et al.. (2017). Rationally Designed PI3Kα Mutants to Mimic ATR and Their Use to Understand Binding Specificity of ATR Inhibitors. Journal of Molecular Biology. 429(11). 1684–1704. 28 indexed citations

Ramurthy, Savithri, Mina Aikawa, Payman Amiri, et al.. (2011). Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(11). 3286–3289. 17 indexed citations

Ramurthy, Savithri, Sharadha Subramanian, Mina Aikawa, et al.. (2008). Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors. Journal of Medicinal Chemistry. 51(22). 7049–7052. 72 indexed citations

Tse, Archie, Katherine G. Rendahl, Tahir Sheikh, et al.. (2007). CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo. Clinical Cancer Research. 13(2). 591–602. 117 indexed citations

McBride, Christopher M., Paul A. Renhowe, Thomas G. Gesner, et al.. (2006). 3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(14). 3789–3792. 16 indexed citations

McBride, Christopher M., Paul A. Renhowe, Carla Heise, et al.. (2006). Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 16(13). 3595–3599. 40 indexed citations

Lin, Xiaodong, Jeremy Murray, Michael Wang, et al.. (2006). Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: Synthesis and SAR studies. Bioorganic & Medicinal Chemistry Letters. 16(16). 4163–4168. 30 indexed citations

Ni, Zhi‐Jie, Paul A. Barsanti, Daniel J. Poon, et al.. (2006). 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3121–3124. 58 indexed citations

10.

Frazier, Kelly, Christopher M. McBride, Sabina Pecchi, et al.. (2006). Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 16(8). 2247–2251. 11 indexed citations

11.

Arnold, S., Sylvia Ma, & Douglas J. Tigert. (1978). A Comparative Analysis of Determinant Attributes in Retail Store Selection. ACR North American Advances. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact